Sarcopenia treatment market revenue is nearly $3.30 billion with

Sarcopenia Treatment Market 2022

Sarcopenia Treatment Market 2022

Global Sarcopenia Treatment Market to Witness Strong Revenue Growth in North America, Followed by Europe: Persistence Market Research.

According to the latest market report released by the company titled “Sarcopenia Treatment Market: Global Industry Analysis 2013 – 2017 and Forecast, 2018 – 2026”, the global sarcopenia treatment market is expected to reach 3,302.0 million by the end of 2026 and growing. at a CAGR of 4.2% over the forecast period.

Get Free Sample Copy of the Sarcopenia Treatment Market Report @ https://www.persistencemarketresearch.com/samples/15694

Company Profiles:

At Abbott Laboratories
Pfizer Inc.
Novartis AG
GlaxoSmithKline Plc.
Nestlé SA
Bayer AG
Sanofi SA
Amway
Cadila Healthcare Ltd.
Eli Lilly and company

Global Sarcopenia Treatment Market: Dynamics

Sarcopenia is categorized by the progressive and generalized loss of skeletal muscle mass and strength, with the risk of adverse effects such as poor quality of life, physical disability and death. Sarcopenia is the age-related loss of muscle mass, after the age of 60 muscle mass declines at an annual rate of 1.5% to 3.0% per year. The prevalence of sarcopenia in people aged 65 and over is estimated at 15%, while it is 50% in people aged 80 and over.

Rising consumption of dietary and nutritional supplements due to health consciousness among the elderly is expected to propel the demand for sarcopenia treatment. The benefits of nutritional supplements to overcome vitamin deficiencies are expected to drive the growth of the sarcopenia treatment market. Most pharmaceutical and food companies invest in the development of new nutritional supplements in order to focus on specific needs. Likewise, increasing investment in the development of nutraceuticals is the major factor expected to drive the growth of the sarcopenia treatment market. The growth of the sarcopenia treatment market is mainly driven by the increasing aging of the population.

Look through the “methodology” employed @ https://www.persistencemarketresearch.com/methodology/15694

According to the National Institutes of Health (NIH), the global population of people aged 80 and over is expected to increase from 126.5 million to 446.6 million between 2015 and 2050. The reduction in the rate of hormonal secretion and the increase in Vitamin deficiencies with aging are expected to create high demand for supplements for the treatment of sarcopenia. Economic factors such as increasing consumer spending from an aging population and rising per capita healthcare expenditures are also expected to drive the demand for supplements for the treatment of sarcopenia. According to the National Health Expenditure Accounts (NHEA), health care spending in the United States increased by 4.3% in 2016, reaching US$3.3 trillion or US$10,348 per person.

However, the rate of diagnosis of sarcopenia is very low because many people are unaware of the symptoms of muscle loss. Additionally, low awareness in the methods of diagnosis and management of sarcopenia due to lack of skilled professionals is expected to hamper the growth of the sarcopenia treatment market. Additionally, unavailability of sarcopenia treatment drugs and high cost of protein supplements are the other factors expected to restrain the growth of the sarcopenia treatment market.

Global Sarcopenia Treatment Market: Forecast

The global sarcopenia treatment market is segmented on the basis of treatment type, distribution channel, and region. Based on type of treatment, the global sarcopenia treatment market is segmented into protein supplement, vitamin D and calcium supplement, and vitamin B12 supplement. The protein supplements segment is expected to account for a high revenue share in the global sarcopenia treatment market during the forecast period.

On the basis of distribution channel, the global sarcopenia treatment market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and hypermarkets & supermarkets. Among all distribution channels, retail pharmacies are expected to be the leading segment of the global sarcopenia treatment market over the forecast period. The online pharmacy segment is expected to account for a high growth rate in the global sarcopenia treatment market owing to the increase in online shopping and the inclination of manufacturers towards digital platforms for marketing and sales.

Based on region, the global sarcopenia treatment market has been segmented into North America, Latin America, Europe, Asia-Pacific, Middle East & Africa. This report assesses the trends driving the growth of each segment and offers analysis and insight into the Sarcopenia treatment potential in specific regions. North America is expected to contribute a high revenue share of the global sarcopenia treatment market over the forecast period. The demand for sarcopenia treatment has increased in North America due to the growing adoption of nutritional supplements, especially by the elderly population due to growing health awareness.

Europe is expected to account for the second largest share of the global sarcopenia treatment market over the forecast period. Developed European countries, such as Germany, UK, France, and Italy are expected to account for a large share of the European sarcopenia treatment market owing to the growing prevalence of lifestyle-associated sarcopenia inactive and obese. The Asia-Pacific region is expected to experience rapid growth in the global sarcopenia treatment market over the forecast period owing to the growing aging population in countries like Japan.

Buy Our Sarcopenia Treatment Market Report Now @ https://www.persistencemarketresearch.com/checkout/15694

Answers to key questions in this report.

What will be the growth rate of the market in the future?
What are the key factors driving the global market?
Who are the major manufacturers in the Market space?
What are the opportunities and threats faced by the vendors in the global industry?
What are sales, revenue, and price analysis by industry regions?

Related Reports-

Heel Pressure Injury Relief Devices Market – https://www.persistencemarketresearch.com/market-research/heel-pressure-injury-relieving-devices-market.asp

Therapeutic Vaccines Market – https://www.persistencemarketresearch.com/market-research/therapeutic-vaccines-market.asp

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York, NY 10007 USA
Telephone in the United States – +1-646-568-7751
USA-Canada Toll Free – +1 800-961-0353
Sales – [email protected]

About Us:

Persistence Market Research (PMR), as a third-party research organization, operates through a proprietary fusion of market research and data analytics to help businesses soar high, regardless of the turbulence encountered due to the financial/natural crises.

This press release was published on openPR.

About Antoine L. Cassell

Check Also

Posters emphasize the prevalence and need for prompt treatment of RVO

Posters presented at the annual meeting of the American Academy of Ophthalmology showed that patients …